Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Gökmen Polar, Yesim ^a   Vladislav, I Tudor ^a   Neelamraju, Yaseswini ^b   Janga, Sarath C ^b   Badve, Sunil ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HOTAIR LONG UNTRANSLATED RNA, HUMAN; LONG UNTRANSLATED RNA; TUMOR MARKER;

BREAST NEOPLASMS; CANCER GRADING; COHORT ANALYSIS; DEFICIENCY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; INFORMATION PROCESSING; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; METABOLISM; MORTALITY; PROGNOSIS; TUMOR VOLUME;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; COHORT STUDIES; DATASETS AS TOPIC; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; NEOPLASM GRADING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RNA, LONG NONCODING; TUMOR BURDEN;

EID: 84924386080     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08765     Document Type: Article

References (35)

1. Shen, X., Qi, P. & Du, X. Long non-coding RNAs in cancer invasion and metastasis. Mod Pathol 28, 4-13 (2015).
2. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22, 1760-1774 (2012).
3. Consortium, E. P. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
4. Bentwich, I. et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37, 766-770 (2005).
5. Cabili, M. N. et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25, 1915-1927 (2011).
6. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22, 1775-1789 (2012).
7. Volders, P. J. et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res 41, D246-251 (2013).
8. Carninci, P. et al. The transcriptional landscape of the mammalian genome. Science 309, 1559-1563 (2005).
9. Wapinski, O. & Chang, H. Y. Long noncoding RNAs and human disease. Trends Cell Biol 21, 354-361 (2011).
10. Gutschner, T. & Diederichs, S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9, 703-719 (2012).
11. Brunner, A. L. et al. Transcriptional profiling of lncRNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol 13, R75 (2012).
12. Qureshi, I. A., Mattick, J. S. & Mehler, M. F. Long non-coding RNAs in nervous system function and disease. Brain Res 1338, 20-35 (2010).
13. Gibb, E. A. et al. Human cancer long non-coding RNA transcriptomes. PLoS One 6, e25915 (2011).
14. Mercer, T. R., Dinger, M. E. &Mattick, J. S. Long non-coding RNAs: insights into functions. Nat Rev Genet 10, 155-159 (2009).
15. Amaral, P. P., Clark, M. B., Gascoigne, D. K., Dinger, M. E. & Mattick, J. S. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res 39, D146-151 (2011).
16. Khalil, A. M. et al.Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106, 11667-11672 (2009).
17. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
18. Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323 (2007).
19. Woo, C. J. & Kingston, R. E. HOTAIR lifts noncoding RNAs to new levels. Cell 129, 1257-1259 (2007).
20. Tsai, M. C. et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689-693 (2010).
21. Bhan, A. et al. Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo. J Steroid Biochem Mol Biol 141, 160-170 (2014).
22. Lu, L. et al. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat 136, 875-883 (2012).
23. Nakagawa, T. et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem Biophys Res Commun 436, 319-324 (2013).
24. Zhuang, Y. et al. Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. J Hematol Oncol 6, 35 (2013).
25. Padua Alves, C. et al. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells 31, 2827-2832 (2013).
26. Chisholm, K. M. et al. Detection of Long Non-Coding RNA in Archival Tissue: Correlation with Polycomb Protein Expression in Primary and Metastatic Breast Carcinoma. PLoS ONE 7, e47998 (2012).
27. Tsai, M. C., Spitale, R. C. & Chang, H. Y. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 71, 3-7 (2011).
28. Sorensen, K. P. et al. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat 142, 529-536 (2013).
29. Liu, X. H. et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 13, 92 (2014).
30. Spitale, A., Mazzola, P., Soldini, D., Mazzucchelli, L. & Bordoni, A. Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol 20, 628-635 (2009).
31. Carey, L. A. et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295, 2492-2502 (2006).
32. Da Silva, L., Clarke, C.& Lakhani, S. R. Demystifying basal-like breast carcinomas. J Clin Pathol 60, 1328-1332 (2007).
33. Rakha, E. A. et al. Prognostic markers in triple-negative breast cancer. Cancer 109, 25-32 (2007).
34. Hammond, M. E. et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28, 2784-2795 (2010).
35. Wolff, A. C. et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 31, 3997-4013 (2013).